F137 (OVER)DOSE Part 1 – documentary adapted for radio
This is a short documentary about medication-related patient safety. The documentary explores and offers an overview of the current challenges and technical solutions related to medication safety to raise awareness about the need to further improve medication-related patient safety.
Unsafe medication practices and medication errors are a leading cause of injury and avoidable harm in health care systems across the world. Globally, the cost associated with medication errors has been estimated at $42 billion USD annually. Errors can occur at different stages of the medication use process.
More than 237 million medication errors are made every year in England, the avoidable consequences of which cost the NHS upwards of £98 million and more than 1700 lives every year, indicate national estimates, published online in the journal BMJ Quality & Safety.
The documentary premiered on 29 June and was accompanied by an expert panel discussion which you can listen to in episode 138.
Watch the documentary: https://www.facesofdigitalhealth.com/blog/overdose-how-can-we-prevent-medication-errors
Speakers in the movie and this episode:
David W. Bates, Medical Director of Clinical and Quality Analysis, Information Systems, Patient Safety Expert and Harvard MD (Clinical & Research Perspective)
Professor John Horn, PharmD, University of Washington School of Pharmacy, coauthor of “The Top 100 Drug Interactions”; A Guide to Patient Management”
Martina Viduka, Practicing Nurse, Co-Founder of Advosense
David Kliff, author and publisher of the Diabetic Investor eNewsletter, former investment advisor, and as a person living with diabetes (Patient Perspective)
Duncan Cripps, Electronic Prescribing and Medication Management Lead at University Hospitals Plymouth NHS Trust (Pharmacist Perspective)
Roni Shiloh, CEO of Seegnal, MD degree, specialized in Psychiatry (CDS provider and doctor perspective)
Hicham Naim, Global Head Integrated & Personalized Patient Care Program, Digital Advisory Board at Takeda (Pharma Perspective)
Marinka Žitnik, Assistant Professor of Biomedical Informatics, Harvard Medical School (Research perspective
Lea Dias, Clinical Pharmacist, Founder and CEO of Quaefacta
Abdulelah Alhawsawi, Ex – founding Director-General of the Saudi Patient Safety Center (SPSC)
Roi Shternin, Founder of the patient-led Israeli society for Dysautonomia (Patient perspective).
Thanks to our Sponsor: Health Resources and Services Administration:
Receive up to $250,000 in student loan repayment in exchange for service in a community disproportionately affected by the opioid crisis. Learn more and apply to join STAR LRP – that stands for the Substance Use Disorder Treatment and Recovery Loan Repayment Program. Applications Close on July 22, 2021